Cilostazol Tarbis

Cilostazol Tarbis is a medication used to improve blood flow and reduce symptoms of intermittent claudication. This oral medication is designed to support cardiovascular health and mobility.

Cilostazol Tarbis is primarily used to enhance blood circulation in the legs, helping to alleviate pain and discomfort associated with intermittent claudication. This condition often results from peripheral artery disease (PAD), where narrowed arteries reduce blood flow. By improving blood flow, Cilostazol Tarbis can help individuals with PAD walk longer distances without experiencing pain. It is also sometimes used to manage other conditions related to poor circulation, though its primary focus is on intermittent claudication.

Common effects of Cilostazol Tarbis may include headaches, dizziness, and stomach upset. Some users might experience diarrhea or a general feeling of weakness. These effects are typically mild and temporary, but if they persist or worsen, it is important to consult a healthcare provider.

Cilostazol Tarbis should be used with caution in individuals with a history of heart conditions, liver disease, or bleeding disorders. It is important to follow the prescribed dosage and not to exceed it without medical advice. Pregnant or breastfeeding women should consult a healthcare provider before using this medication.

Cilostazol Tarbis may interact with certain medications, including blood thinners, other cardiovascular drugs, and CYP3A4 inhibitors. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should also be moderated while using this medication.